MBX (MBX Biosciences) Total Assets: $452.70 Mil (As of Mar. 2026)


MBX MBX Biosciences Inc MBX
12 GF Score
Price $52.21
! 2 Warning Signs
View Full Analysis

What is MBX Biosciences Total Assets?

MBX Biosciences MBX +3.77% 12 Total Assets is $452.70 Mil as of Mar. 2026. GuruFocus rates MBX with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

MBX Biosciences's Total Assets for the quarter that ended in Mar. 2026 was $452.70 Mil.

During the past 12 months, MBX Biosciences's average Total Assets Growth Rate was 79.10% per year. During the past 3 years, the average Total Assets Growth Rate was 63.20% per year.

During the past 4 years, MBX Biosciences's highest 3-Year average Total Assets Growth Rate was 63.20%. The lowest was 63.20%. And the median was 63.20%.

Total Assets is connected with ROA %. MBX Biosciences's annualized ROA % for the quarter that ended in Mar. 2026 was -22.45%. Total Assets is also linked to Revenue through Asset Turnover. MBX Biosciences's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

MBX Biosciences  (NAS:MBX) Total Assets Explanation

Total Assets is connected with ROA %.

MBX Biosciences's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-94.068/( (385.144+452.701)/ 2 )
=-94.068/418.9225
=-22.45 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

MBX Biosciences's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (385.144+452.701)/ 2 )
=0/418.9225
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

MBX Biosciences Total Assets Related Terms

MBX Biosciences Total Assets Historical Data

* Premium members only.

The historical data trend for MBX Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MBX Biosciences Total Assets Chart

MBX Biosciences Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Assets
45.10 84.18 268.54 385.14

MBX Biosciences Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 245.93 231.52 400.08 385.14 452.70
MBX
12GF Score
MBX Biosciences Inc MBX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MBX Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

MBX Biosciences's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=369.223+15.921
=385.14

MBX Biosciences's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=437.756+14.945
=452.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $452.70 Mil mean?
MBX Biosciences (MBX) has a Total Assets of $452.70 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on MBX Biosciences and its competitors.
Is MBX Biosciences' Total Assets too high?
MBX Biosciences' current Total Assets is $452.70 Mil. Overall, MBX Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MBX Biosciences' Total Assets compare to ARDX and INBX?
MBX Biosciences' Total Assets of $452.70 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on MBX Biosciences and its competitors. MBX Biosciences's current Total Assets is $452.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MBX Biosciences stock overvalued right now?
MBX Biosciences (MBX) has a current Total Assets of $452.70 Mil. The current Total Assets is $452.70 Mil. MBX Biosciences' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For MBX Biosciences (MBX), the current Total Assets is $452.70 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MBX Biosciences Business Description

Address 11711 N. Meridian Street, Suite 300, Carmel, IN, USA, 46032
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
12GF Score

Get the complete analysis for MBX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$52.21
Price